These observations are in agreement with the elevated glucocorticoid levels in adulthood found associated with a higher risk of developing AD, by altering glial function, Tau and amyloid lesions, and synaptic plasticity (Vyas et al., 2016). The gene discussed is MAPT; the disease is amyloidosis.